Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Lawrence Dougan, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Michael Dougan and Stephanie Dougan.
Connection Strength

7.311
  1. SMAC mimetics throw a molecular switch to control TH17 responses. Sci Signal. 2019 08 27; 12(596).
    View in: PubMed
    Score: 0.861
  2. Programmable bacteria as cancer therapy. Nat Med. 2019 07; 25(7):1030-1031.
    View in: PubMed
    Score: 0.852
  3. GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation. Immunity. 2019 04 16; 50(4):796-811.
    View in: PubMed
    Score: 0.839
  4. Regulation of innate and adaptive antitumor immunity by IAP antagonists. Immunotherapy. 2018 07; 10(9):787-796.
    View in: PubMed
    Score: 0.790
  5. Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs. Cancer Immunol Res. 2018 04; 6(4):389-401.
    View in: PubMed
    Score: 0.775
  6. Targeting Immunotherapy to the Tumor Microenvironment. J Cell Biochem. 2017 10; 118(10):3049-3054.
    View in: PubMed
    Score: 0.735
  7. Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis. Allergy. 2021 Oct 06.
    View in: PubMed
    Score: 0.249
  8. cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes. Sci Transl Med. 2021 05 19; 13(594).
    View in: PubMed
    Score: 0.243
  9. Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Cancer Discov. 2021 Oct; 11(10):2564-2581.
    View in: PubMed
    Score: 0.242
  10. Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 2021 03 18; 184(6):1575-1588.
    View in: PubMed
    Score: 0.239
  11. Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH. Open Biol. 2020 02; 10(2):190235.
    View in: PubMed
    Score: 0.222
  12. Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A. 2018 04 10; 115(15):3912-3917.
    View in: PubMed
    Score: 0.195
  13. IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells. Cancer Immunol Res. 2018 01; 6(1):25-35.
    View in: PubMed
    Score: 0.191
  14. Localized CD47 blockade enhances immunotherapy for murine melanoma. Proc Natl Acad Sci U S A. 2017 09 19; 114(38):10184-10189.
    View in: PubMed
    Score: 0.188
  15. Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy. . 2017 03; 16(3):428-439.
    View in: PubMed
    Score: 0.180
  16. Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity. Cancer Immunol Res. 2013 Aug; 1(2):99-111.
    View in: PubMed
    Score: 0.141
  17. IAP inhibitors enhance co-stimulation to promote tumor immunity. J Exp Med. 2010 Sep 27; 207(10):2195-206.
    View in: PubMed
    Score: 0.116
  18. Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv. 2021 Jan; 1(1):ltab011.
    View in: PubMed
    Score: 0.061
  19. Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy. Cell. 2020 08 06; 182(3):655-671.e22.
    View in: PubMed
    Score: 0.057
  20. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med. 2018 04 11; 10(436).
    View in: PubMed
    Score: 0.049
  21. PD-L1 is an activation-independent marker of brown adipocytes. Nat Commun. 2017 09 21; 8(1):647.
    View in: PubMed
    Score: 0.047
  22. Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans. PLoS Pathog. 2015 Oct; 11(10):e1005188.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.